(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.08%) $79.06
(5.02%) $2.03
(0.10%) $2 313.40
(0.68%) $26.93
(0.85%) $963.00
(-0.07%) $0.932
(-0.27%) $11.00
(-0.09%) $0.798
(-2.30%) $91.12
4 days till quarter result
(amc 2024-05-06)
Expected move: +/- 5.27%
2.58% $ 13.91
@ $13.07
Emitido: 14 feb 2024 @ 15:52
Retorno: 6.47%
Señal anterior: feb 14 - 09:30
Señal anterior:
Retorno: 4.73 %
Live Chart Being Loaded With Signals
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases...
Stats | |
---|---|
Volumen de hoy | 71 924.00 |
Volumen promedio | 228 881 |
Capitalización de mercado | 294.28M |
EPS | $0 ( 2024-02-07 ) |
Próxima fecha de ganancias | ( $-1.260 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.12 |
ATR14 | $0.0270 (0.19%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-29 | Kowalsky Matthew Paul | Buy | 150 000 | Stock Option (right to buy) |
2024-04-29 | Kowalsky Matthew Paul | Buy | 0 | |
2024-03-06 | Vance Terry | Buy | 15 700 | Stock Option (right to buy) |
2024-03-06 | Russell Lesley | Buy | 15 700 | Stock Option (right to buy) |
2024-03-06 | Peterson Kristine | Buy | 15 700 | Stock Option (right to buy) |
INSIDER POWER |
---|
75.20 |
Last 99 transactions |
Buy: 1 413 491 | Sell: 286 116 |
Volumen Correlación
Enanta Pharmaceuticals Correlación
10 Correlaciones Más Positivas | |
---|---|
MODV | 0.977 |
CNXC | 0.977 |
SBSI | 0.975 |
NURO | 0.975 |
HMST | 0.974 |
TRVG | 0.971 |
NWL | 0.97 |
INDB | 0.97 |
FSFG | 0.97 |
TBNK | 0.97 |
10 Correlaciones Más Negativas | |
---|---|
AGGR | -0.983 |
TBSA | -0.983 |
LEGA | -0.982 |
ACQR | -0.981 |
AHRN | -0.977 |
FRON | -0.976 |
LGAC | -0.976 |
FRSG | -0.975 |
HERA | -0.975 |
CFIV | -0.975 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Enanta Pharmaceuticals Correlación - Moneda/Commodity
Enanta Pharmaceuticals Finanzas
Annual | 2023 |
Ingresos: | $79.20M |
Beneficio Bruto: | $76.83M (97.01 %) |
EPS: | $-6.38 |
FY | 2023 |
Ingresos: | $79.20M |
Beneficio Bruto: | $76.83M (97.01 %) |
EPS: | $-6.38 |
FY | 2022 |
Ingresos: | $86.16M |
Beneficio Bruto: | $83.19M (96.55 %) |
EPS: | $-5.91 |
FY | 2021 |
Ingresos: | $97.07M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-3.92 |
Financial Reports:
No articles found.
Enanta Pharmaceuticals
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico